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ABSTRACT DNA damage-inducible mutagenesis in Esch-
erichia coli is largely dependent upon the activity of the UmuD
(UmuD') and UmuC proteins. The intracellular level of these
proteins is tightly regulated at both the transcriptional and
the posttranslational levels. Such regulation presumably al-
lows cells to deal with DNA damage via error-free repair
pathways before being committed to error-prone pathways.
We have recently discovered that as part of this elaborate
regulation, both the UmuD and the UmuC proteins are rapidly
degraded in vivo. We report here that the enzyme responsible
for their degradation is the ATP-dependent serine protease,
Lon. In contrast, UmuD' (the posttranslational product and
mutagenically active form of UmuD) is degraded at a much
reduced rate by Lon, but is instead rapidly degraded by
another ATP-dependent protease, ClpXP. Interestingly,
UmuD' is rapidly degraded by ClpXP only when it is in a
heterodimeric complex with UmuD. Formation of UmuD/
UmuD' heterodimers in preference to UmuD' homodimers
therefore targets UmuD' protein for proteolysis. Such a
mechanism allows cells to reduce the intracellular levels of the
mutagenically active Umu proteins and thereby return to a
resting state once error-prone DNA repair has occurred. The
apparent half-life of the heterodimeric UmuD/D' complex is
greatly increased in the clpX::Kan and clpP::Kan strains and
these strains are correspondingly rendered virtually UV non-
mutable. We believe that these phenotypes are consistent with
the suggestion that while the UmuD/D' heterodimer is mu-
tagenically inactive, it still retains the ability to interact with
UmuC, and thereby precludes the formation of the mutagen-
ically active UmuD'2C complex.
Exposure of Escherichia coli to many DNA-damaging agents
that cause bulky adducts often results in a significant increase
in the mutation frequency. While many DNA repair and
recombination proteins are induced as a consequence ofDNA
damage, only a few gene products are required for this
so-called "SOS mutagenesis" (for review, see ref. 1). Key
participants in this process are the UmuD and UmuC proteins,
which are thought to interact with RecA and DNA polymerase
III in such a way as to facilitate translesion DNA synthesis
(2-5). Perhaps because the mutagenic pathway is, by defini-
tion, error-prone, the activity of the Umu proteins is tightly
regulated. For example, (i) the umuDC operon is tightly
repressed by LexA protein and would be expected to be only
fully derepressed under conditions of severe DNA damage (6);
(ii) even when fully expressed, both the UmuD (7) and UmuC
(7-9) proteins are labile and are rapidly degraded in vivo; (iii)
UmuD protein is functionally inactive until it undergoes an
inefficient RecA-mediated autoproteolytic cleavage reaction
that generates the mutagenically active UmuD' protein (10-
12); and (iv) UmuD' interacts with UmuD+ to generate a
mutagenically inactive UmuD+/UmuD' heterodimer in pref-
erence to an active UmuD' homodimer (13).
Given the elaborate mechanisms that E. coli uses to keep the
activity of the Umu proteins to a minimum, avoiding gratuitous
mutagenesis, we were perplexed by the apparent stability of
UmuD'2C (7) and wondered if a mechanism existed to quickly
reduce the level of the uncomplexed Umu proteins. One
feasible mechanism to achieve this goal would be to target the
Umu proteins for proteolytic degradation. E. coli possesses a
number of proteases (for reviews, see refs. 14 and 15), with the
best characterized being the ATP-dependent serine proteases,
Lon and Clp. Lon is a homotetramer of -450 kDa that is
known to degrade a number of cellular proteins including SulA
and RcsA (14, 15). The Clp protease, in contrast, is a large
heterooligomeric structure that consists of a protease subunit
(ClpP) and a specificity subunit consisting of ClpA, ClpB,
ClpX, or ClpY (14, 15). ClpAP has previously been shown to
degrade a number of substrates (16) including ClpA itself (17)
and the bacteriophage P1 RepA protein (18). By comparison,
studies have shown that substrates of ClpXP include the
bacteriophage-encoded proteins such as PhD (phage P1) (19),
0 protein (phage A) (20), and MuA (phage Mu) (21-23), and
the chromosomally expressed starvation sigma factor, RpoS
(o-s) (24). In addition to acting in concert with ClpP to promote
proteolysis, both ClpA and ClpX have been shown to possess
chaperonin-like activity independent of ClpP (18, 25, 26).
We were interested in determining what role proteolysis
might play in regulating the intracellular levels of the Umu
proteins and have therefore determined the in vivo stability of
the UmuD, UmuD' and UmuC proteins in various lon, cipA,
clpB, clpX, and clpP strains.
Analysis revealed that the Umu proteins are indeed sub-
strates of the Lon and ClpXP proteases. Lon appears to act by
rapidly degrading UmuD before it is converted to the muta-
genically active form of UmuD'. Likewise, Lon also degrades
UmuC before it becomes stabilized by UmuD' (7, 8). In
contrast, ClpXP acts at a later stage (after activation of
UmuD') by specifically degrading UmuD' when it is associated
with UmuD in a UmuD/UmuD' heterodimer. The implica-
tions and consequences of these proteolytic pathways for SOS
mutagenesis are discussed.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. The E. coli K-12 strains
used in this study are listed in Table 1. All new strains were
constructed by standard methods of generalized P1 transduc-
tion (30). Plasmids encoding UmuD (pRW362) (7), UmuD'
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Table 1. E. coli K-12 strains used in this study
Strain Relevant genotype Ref. or source
TK603 recA+ lexA+ hisG4 27
SG22099 clpA319::Kan 28
SG22100 clpB::Kan 25
TS356 clpP::Kan T. Shrader
SG22101 clpX::Kan 28
SG12047 lonl46::TnJO 29
SG22094 rcsAJ66::Kan Alon clpPJ::cat S. Gottesman
RW110 recA+ lexA+ hisG4 suLA211 Section on DNA Replication, Repair
and Mutagenesis lab collection
EC8 recA+ lexA+ uvrA6 hisG4 A(umuDC)596::ermGT 7
EC10 recA+ lexA51(Def) A(umuDC)596::ermGT 7
EC18 recA+ lexA51(Def) A(umuDC)596::ermGT Ion146::TnlO P1.SG12047 x EC10
EC22 recA + lexA51(Def) A(umuDC)596::ermGT cipP::Kan P1.TS356 x EC10
EC24 recA+ lexA51(Def) A(umuDC)596::ermGT cipA319::Kan P1.SG22099 x EC10
EC26 recA + lexA51(Def) A(umuDC)596::ermGT cipB::Kan P1.SG22100 x EC10
EC28 recA+ lexA5J(Def) A(umuDC)596::ermGT clpX::Kan P1.SG22101 x EC10
EC34 recA + lexA + uvrA6 hisG4 cipP::Kan P1.TS356 x TK603
EC202 recA+ lexA+ uvrA6 hisG4 cipA319::Kan P1.SG22099 x TK603
EC204 recA+ lexA+ uvrA6 hisG4 cipB::Kan P1.SG22100 x TK603
EC206 recA + lexA + uvrA6 hisG4 clpX::Kan P1.SG22101 x TK603
EC210 recA+ IexA+ uvrA6 hisG4 suUA211 rcsA166::Kan P1.SG22094 x RW110
EC212 recA I lexA I uvrA6 hisG4 sulA211 rcsA166::Kan Ion146::TnlO P1.SG12047 x EC210
(pRW66) (31), and UmuC (pRW124) (31) have been de-
scribed. Plasmid pRW366, which expresses UmuD' and a
noncleavable UmuDl protein in cis (from a low-copy-number
plasmid), was constructed by cloning a 1631-bp BglII-EcoRI
fragment from pGW2053 (13) into the similarly digested
vector, pRW134 (32). Although UmuDl carries a mutation
that changes Pro27 -> Ser27 and renders the protein noncleav-
able (33), the mutant protein is expressed at similar steady-
state levels (13, 33) and has the same stability as the wild-type
UmuD protein (unpublished observations). While both the
UmuD' and UmuD1 proteins are expressed from their natural
LexA-regulated operator/promoter sequences, previous ex-
periments have shown that UmuD (D1) is produced at some-
what higher levels than UmuD' (8). Recent studies suggest,
however, that UmuD' is much more stable than UmuD (7). As
a consequence of this differential expression and stability, we
expect the steady-state levels of the pRW366-encoded UmuDl
and UmuD' proteins to be approximately stoichiometric.
In Vivo Stability of the Umu Proteins in Various Genetic
Backgrounds. The stability of the Umu proteins in the
A(umuDC)596::ermGT recA+ lexASl(Def) strain, EC10, and
its isogenic protease-deficient derivatives was studied as de-
scribed previously (7). This assay allows us to follow the
stability of the Umu proteins after protein synthesis is inhibited
by the addition of chloramphenicol. Similar assay conditions
have been previously used in studying the stability of many
proteins, including LexA and the bacteriophage Mu repressor
proteins (21, 34). Briefly, cells were grown at 37°C in Luria-
Bertani media until the early exponential phase. At time zero,
100 ,ug/ml chloramphenicol was added to the culture and
aliquots were removed at various times thereafter. Cells were
harvested by centrifugation and the resulting cell pellet was
resuspended in electrophoresis sample buffer. Cells were lysed
by repeated freeze-thaw cycles and the resulting extract was
subjected to electrophoresis in either SDS/15% PAGE gels
(for UmuC) or SDS/17% PAGE gels (for UmuD and
UmuD'). Proteins were electrotransferred to an Immobilon P
membrane (Millipore) and subsequently probed either with a
1:10,000 dilution of affinity-purified polyclonal antisera raised
against UmuD/UmuD' or with a 1:20,000 dilution of poly-
clonal antisera raised against UmuC (31, 35). The Umu
proteins were subsequently visualized using the CSPD-
Western light chemiluminescent assay (Tropix, Bedford, MA).
Membranes were exposed to Kodak X-Omat or Bio-Max film
for periods of 1-20 min and the film subjected to densitometric
analysis using the software NIH IMAGE (version 1.59; National
Institutes of Health, Bethesda). While the estimated half-lives
of the Umu proteins determined by this method have been
found to be shorter than those previously described (7, 8), the
same relative stability of the Umu proteins is, however,
observed and we believe that this approach is a valid repre-
sentation of the stability of the Umu proteins in vivo (7).
The UmuD/D' antisera is very specific and only recognizes
the UmuD and UmuD' proteins in whole-cell E. coli extracts.
The UmuC antisera is also specific but cross-reacts with
another protein that is -5 kDa smaller than UmuC. While the
identity of this protein is unknown, it serves as a useful internal
control ensuring that equal amounts of protein extract have
been applied to the gel (7).
Mutagenesis Assays. UV-induced reversion of the
hisG4(0c) allele found in TK603 and its protease-deficient,
isogenic derivatives was studied as previously described (31).
Briefly, cells were grown in Luria-Bertani medium until
early-log phase, at which point they were harvested and
resuspended in SM buffer (30). Cells were exposed to UV light
and appropriate dilutions were plated on minimal agar plates
supplemented with a trace amount of histidine. Mutations
were scored after 4 days incubation at 37°C and mutation
frequencies calculated as described by Sedgwick and Bridges
(36).
RESULTS
Degradation of UmuD and UmuC Proteins by the Lon
Protease. We have recently demonstrated that the UmuD and
UmuC proteins are labile in vivo (7). We were therefore
interested in determining which ofE. coli's many proteases was
responsible for their degradation. Clues to the identity of the
protease came from observations that certain strains exhibiting
extremely stable levels of UmuC also exhibited a mucoid
phenotype (unpublished observations). Such a phenotype is
often associated with defects in the Lon protease [because of
an increase in capsule synthesis mediated by the positive
regulator, RcsA (37-39)]. To test the hypothesis that Lon may
be involved in the degradation of the Umu proteins, we
compared the stability of each of the separately plasmid-
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encoded Umu proteins in isogenic AumuDC lexASl(Def)
strains carrying either lon+ or lon- alleles (Fig. 1). As clearly
seen, the presence of the lonl46::TnlO mutation had a dra-
matic effect on the stability of both the UmuD and the UmuC
proteins. This observation strongly suggests that the UmuD
and UmuC proteins are substrates of the Lon protease. In
contrast, there was not a dramatic difference in UmuD'
stability between the lon- and lon+ strains. This result seems
to indicate that UmuD' may also be a substrate of Lon but to
a much lesser extent.
While the experiments reported here have, for simplicity,
followed the stability of the UmuD, UmuD', or UmuC pro-
teins when expressed alone, similar results were obtained when
we coexpressed the UmuDC or UmuD'C proteins (unpub-
lished results). Under these conditions, the initial stability of
the Umu proteins depends upon the presence of its cognate
partner in the lon+ background (7), but in the Ion- strain, the
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FIG. 1. Stability of UmuD, UmuD', and UmuC proteins in isogenic
Ion+ andlon- strains. Plasmids expressing UmuD (pRW362) (A),
UmuD' (pRW66) (B), and UmuC (pRW124) (C) were introduced into
the A(umuDC)596::ermGT recA+ lexA5l(Def)lon+ strain EC10 and
the A(umuDC)596::ermGTrecA+ lexASl(Def) lon- strain EC18, and
the relative stability of the Umu proteins was measured after protein
synthesis was inhibited by the addition of chloramphenicol (100
,ug/ml) at time zero. Additional aliquots were removed at 10-min
intervals for the UmuD and UmuD' experiments and at 6-min
intervals for UmuC. Approximately 100,ug of extract was used to
visualize UmuC in thelon+ strain, while '40,ug of extract was used
to visualize UmuC in thelon strain and the UmuD and UmuD'
proteins in thelon+ andlon- strains.
stability of UmuD, UmuD', and UmuC was identical to that
when expressed alone (Fig. 1). This might be expected for
UmuD since it is naturally expressed in a 12-fold excess over
UmuC (40), but it suggests that UmuC protein is also degraded
when uncomplexed and that by forming a UmuD'2C complex,
UmuC is partially protected from Lon-dependent degradation.
It has previously been suggested that LexA51 protein is also
stabilized in a Ion- strain (41). However, all of the vectors used
in this study express the Umu proteins from their LexA-
regulated promoter. If such a stabilization of LexA51 protein
does occur in a Ion - strain, it does not apparently affect the
expression of the Umu proteins (Fig. 1 and unpublished
observations)
We have also analyzed the half-life of the UmuD, UmuD',
and UmuC proteins when expressed separately in a set of
isogenic strains that were Ion+ but carried mutations in cipA,
cipB, cipX, or cipP. Under these conditions, the stability of all
three proteins remained essentially unchanged when com-
pared with their parental clp+ control, which suggests that
homodimeric UmuD or UmuD' proteins and the monomeric
UmuC protein are not substrates of the ClpAP, ClpBP, or
ClpXP proteases (unpublished observations).
Degradation of UmuD' in a UmuD/UmuD' Heterodimer by
the ClpXP Protease. As noted above, in the AumuDC back-
ground, UmuD' is moderately stable and is relatively insen-
sitive to the actions of the Lon, ClpAP, ClpBP, or ClpXP
proteases. Furthermore, in the AumuDC background, UmuD'
interacts with UmuC to form a very stable and mutagenically
active UmuD'2C complex (7,8). Given the tight regulation that
E. coli appears to have evolved to keep the mutagenically
active UmuD'C complex to a minimum, it seems paradoxical
that a cell would maintain high steady-state levels of the
mutagenically active UmuD'C complex long after most DNA
damage would be expected to have been repaired. We there-
fore hypothesized that there must be some mechanism avail-
able that would regulate the intracellular levels of the
UmuD'C proteins. We considered the possibility that the
formation of UmuD+/UmuD' heterodimers might provide
such a regulatory function. In the experiments described
above, the UmuD' protein is expressed in a AumuDC back-
ground and can therefore only form homodimers. This situa-
tion rarely occurs in umul cells, as UmuD' is normally
generated by the posttranslational processing of UmuD pro-
tein. Furthermore, previous studies have shown that in vitro,
UmuD+ and UmuD' (which both form homodimers) prefer-
entially form heterodimers (13). Since conversion of UmuD to
UmuD' is inefficient in vivo (40), it seems likely that at any
given time, most of the UmuD' will be complexed with UmuD
in a UmuD/UmuD' heterodimer. We were therefore inter-
ested in analyzing the stability of UmuD' under conditions
where it might be expected to be in a heterodimeric complex
with UmuD rather than in a homodimer with itself. To do so,
we used the AumuDC strains harboring a low-copy-number
plasmid, pRW366, that expresses UmuD' and a noncleavable
UmuDl protein (13, 33) in cis (Fig. 2A). (The use of a
noncleavable UmuD protein reduced the possibility that there
may be some gratuitous generation of UmuD' from UmuD.)
As noted in Materials and Methods, this plasmid should, in
theory, express approximately equimolar steady-state levels of
UmuD' and UmuDl proteins. While the stability of the
mutant UmuDl protein was comparable to the wild-type
protein (compare Fig.1A with Fig. 2B), analysis revealed that
in a wild-type background, steady-state levels of UmuD' were,
in stark contrast to the homodimeric UmuD' protein, barely
detectable (compare Fig.1B with Fig. 2B). Similar results were
also obtained when pRW366 was introduced into the
clpA319::Kan and clpB::Kan strains (Fig. 2B). In contrast,
when the very same plasmid was introduced into a clpX::Kan
or cipP::Kan strain, UmuD' was expressed and was apparently
very stable (Fig. 2B). Interestingly, UmuDl protein also
Genetics: Frank et al.
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pler interpretation is that the UmuDl/UmuD' heterodimer is
a substrate of ClpXP. This seems unlikely, however, since only
Eco RI UmuD' appears to be rapidly degraded in clpXP+ strains (Fig.
2B), and if the heterodimer were a substrate of ClpXP, both
UmuDl/UmuD' might be expected to be degraded at equal
efficiencies.
Effects of lon and clpXP Mutations on UV-Induced Mu-
tagenesis. Given the effects that Lon and ClpXP play in the
degradation of the Umu proteins, we were interested in
-UmuDl determining the UV-mutagenesis phenotype of lon and clpXP
strains. Although the lon mutant exhibits greatly elevated
steady-state levels of both UmuD and UmuC proteins, this
70 80 does not seem to have a dramatic effect on UV-induced
mutagenesis (Fig. 3). This observation is consistent with earlier
studies on E. coli B/r strains that are phenotypically Lon- but
are perfectly UV mutable (42). At first glance, this might seem
paradoxical, especially given the observation that the muta-
genically inactive UmuD protein is dramatically stabilized in
the lon- strains. Furthermore, any mutagenically active
UmuD' protein produced might be expected to be complexed
with UmuD. It must be emphasized, however, that all of these
protein-protein interactions are in a dynamic equilibrium and
that increasing the cellular concentration of UmuD also leads
to an increase in the level of UmuD'. At any given time,
UmuD' will dissociate from UmuD+ (or UmuDl) and reas-
sociate with UmuC to form a mutagenically active UmuD'2C
complex. In a lon- strain, it seems that such interactions are,
in fact, greatly enhanced since the normally limiting UmuC
protein is much more abundant than in the Ion+ background
(Fig. 1C).
In dramatic contrast, both the clpX::Kan and clpP::Kan
strains were rendered phenotypically poorly mutable by UV
light when compared with the isogenic clp+ strain, TK603 (Fig.
3). Based upon the data presented in Fig. 2B, we expect that
UmuD'- q1 _ _ _
c/pX::kan
UmuDl1 _41 _
UmuD'-- Eb '1__ 4
FIG. 2. Stability of UmuD' and UmuDl proteins in various clp
strains. (A) Arrangement of the umuD' and umuDI genes in pRW366;
a full description ofpRW366 can be found in the text. Since the umuD'
and umuDI genes contain identical operator/promoter regions, the
UmuD' and UmuD1 proteins are expected to be produced in equimo-
lar amounts. (B) The stability of the UmuD1 and the UmuD' proteins
analyzed by introducing plasmid pRW366 into a set of
A(umuDC)596::ermGT recA+ lexASl(Def) isogenic strains: EC10
(clp+), EC24 (clpA319::Kan), EC26 (clpB::Kan), EC28 (cipX::Kan),
and EC22 (clpP::Kan). The relative stability of UmuDl and UmuD'
proteins was measured after protein synthesis was inhibited by the
addition of chloramphenicol (100 ,ug/ml) at time zero. Additional
aliquots were removed at 10-min intervals.
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appears to be dramatically stabilized in the clpX::Kan and
clpP::Kan strains (Fig. 2B).
Together, these observations suggest to us that (i) UmuD'
is only rapidly degraded by the ClpXP protease when it is
complexed with UmuD; and (ii) that UmuD is normally
degraded by Lon when it is either monomeric or homodimeric,
but not when it is in a heterodimer with UmuD'. Furthermore,
the fact that there appears to be some limited degradation of
UmuDi in the clpP strain but not the clpX strain indicates that
the ClpX chaperone might play a role in the assembly/
disassembly of the heterodimeric UmuD/D' complex. A sim-
UV (Jlm2)
FIG. 3. Ability of various protease-proficient and protease-
deficient strains to promote UV-induced mutagenesis. TK603 (clp+)
(-), EC34 (clpP::Kan) (A), EC206 (clpX::Kan) (U), and EC212
(lon146::TnJO) (0). (EC212 also carries mutations in sulA and rcsA,
which avoid the UV-induced lethal filamentation and mucoid colony
formation associated with mutations in lon.) For all of the strains
shown, the data represent the means from at least three independent
experiments. Experiments with EC202 (clpA319::Kan) and EC204
(clpB::Kan) revealed that they exhibited identical UV-induced mu-
tagenesis phenotypes when compared with their clp+ parent, TK603,
and are not shown for simplicity.
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AumuDC recA- IexA51(Def) cIpX::kan
pUmuC
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pUmuC/pUmuD'-UmuDl
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FIG. 4. Effect of coexpressing UmuD' and UmuDl proteins on
UmuC stability. Plasmids expressing UmuC alone (pRW124) or
coexpressing UmuD'/D1 (pRW366) were introduced into the
A(umuDC)596::ermGT recA+ lexA51(Def) strain EC10 and its
clpX::Kan derivative, EC28. The relative stability of UmuC was
assayed after protein synthesis was inhibited by the addition of
chloramphenicol (100 ,ug/ml) at time zero. Additional aliquots were
removed at 10-min intervals. Approximately 100 ,ug of cell extract was
used to visualize UmuC when expressed on its own from pRW124,
whereas only '40 Ag of extract was used to visualize UmuC when
coexpressed with UmuD'/UmuD1. The position ofUmuC is indicated
by an arrow at the left of the Fig.
the chromosomally encoded UmuD+ and UmuD' proteins are
more likely to exist as a heterodimer in these strains; we believe
that this observation is consistent with the hypothesis that
heterodimers are mutagenically inactive (13). The poor mu-
tability of the clpX and clpP strains also suggests that the
wild-type ClpXP proteins may actually play an indirect role in
promoting mutagenesis. Alternatively, ClpXP might affect
some other protein required for SOS mutagenesis. This latter
hypothesis seems unlikely, however, given that AumuDC clpXP
strains are perfectly mutable if provided plasmid-encoded
levels of Umu proteins (unpublished observations).
Effects of Stable UmuDl/UmuD' Heterodimer Formation
on the in Vivo Stability of UmuC Protein. It has previously
been demonstrated that UmuD' homodimers are much more
efficient at stabilizing UmuC in vivo than UmuD homodimers
(7, 8). One possible explanation for the poor mutability of the
clpXP strains is that the stably maintained but mutagenically
inactive UmuD+/UmuD' heterodimer can also interact with
UmuC in vivo, thereby precluding any UmuD'2C interactions.
This hypothesis is strengthened by the in vitro studies of
Woodgate et al. (35), who found that UmuC protein was
retained on a UmuD+/UmuD' protein affinity column, a
property that facilitated UmuC purification. We have tested
this hypothesis by analyzing the in vivo stability of a plasmid-
encoded UmuC protein in a recA+ lexA51(Def)
A(umuDC)596::ermGT clpX::Kan strain in the absence and
presence of the plasmid-encoded UmuDl/UmuD' proteins
(Fig. 4). In the absence of the UmuDl/D' proteins, UmuC
remained labile in the clpXstrain and exhibited similar stability
to the clp+ control strain (compare with Fig. 1C). In contrast,
however, UmuC was greatly stabilized in the presence of the
UmuDl/UmuD' proteins. Indeed, the extent of UmuC sta-
bilization was similar to that seen when coexpressed with
homodimeric UmuD' protein (7). We believe that such an
observation is indicative of an interaction between the
UmuDl/UmuD' heterodimer and UmuC proteins in vivo.
DISCUSSION
Regulation of the Intracellular Levels of UmuD, UmuD',
and UmuC by the Lon and ClpXP Serine Proteases. As noted
in the Introduction, previous experiments have suggested that
the activity of the E. coli Umu proteins is tightly regulated at
several steps. As part of this complex regulation, we have
identified Lon as the protease that degrades the UmuD and
UmuC proteins before they become mutagenically active. Our
observation that the ClpXP protease acts on UmuD' primarily
when it is dimerized with UmuD+ (or UmuDl) protein adds
yet another level of complexity.
It is becoming increasingly clear that the level of SOS
mutagenesis permitted in a cell exposed to any given mutagen
is dependent upon a series of intimate protein-protein inter-
actions and the association/dissociation constants that deter-
mine these interactions. For example, although UmuD is
thought to primarily exist in a dimeric state in solution, recent
structural analysis suggests that for it to undergo autocatalytic
cleavage, it must be in a monomeric state (43). Thus, the ability
of a cell to produce UmuD' is the product of several reactions
(Fig. 5): (i) The efficiency of the UmuD-Lon interaction; (ii)
the ability of the dimeric UmuD protein to dissociate and form
monomers; and (iii) the efficiency of the UmuD monomer's
interaction with a RecA nucleoprotein filament (itself a com-
plex reaction). Once generated, the monomeric UmuD' pro-
tein faces at least two options: (i) it can interact with itself to
form UmuD' homodimers, which can then interact with, and
stabilize, UmuC to form the mutagenically active UmuD'2C
complex; or (ii) it can heterodimerize with UmuD (since
UmuD is, in most situations, in a vast excess over UmuD'). If
it chooses the latter pathway, UmuD' is rapidly degraded by
ClpXP, thereby releasing UmuD protein so that it too, can be
degraded either in a monomeric or in a dimeric state by Lon.
In a wild-type cell, all of these reactions are undoubtedly in
a dynamic equilibrium, which, although favoring degradation
mO '
UmuD
dimer
** *
*mO*
UmuD-Lon
UmuD degradation
&-7O --O D
UmuD UmuD'
monomer monomer
CD
UmuD'
dimer
UmuD'2 C
complex
Mutagenically active
UmuDlD' UmuDlD'C UmuC
Mutagenically inactive
E
UmuD/D'-
(D'-ClpXP)
UmuD' degradation
* **
UmuC-Lon
UmuC degradation
FIG. 5. Protein-protein interactions that result in degradation of
the Umu proteins and thereby affect SOS mutagenesis. A full descrip-
tion of the numerous and complex interactions is described in the
Discussion. Virtually all of these reactions are reversible, although,
where noted, some are clearly more favored than others. The obvious
exceptions are those interactions that lead to proteolysis, such as
conversion of UmuD to UmuD' or those leading to the complete
degradation of the UmuD, UmuD', and UmuC proteins. For simplic-
ity, we have not depicted the additional protein-protein interactions
between UmuD-RecA, UmuD-UmuC, UmuD'-RecA, UmuD'2C-
RecA, and UmuC-Hsp6O/Hsp7O that also modulate the level of SOS
mutagenesis. See ref. 7 for a full description of these interactions.
Although we have depicted Lon as interacting with a dimer of UmuD,
it is equally plausible that Lon interacts with UmuD when it is in a
monomeric state. Mutations in either clpX or clpP result in a dramatic
shift in the equilibrium of these interactions. As a result, the muta-
genically inactive UmuD/UmuD' heterodimer is maintained, and
presumably renders the cell phenotypically nonmutable by successfully
competing with homodimeric UmuD' for a binding site on UmuC.
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of the Umu proteins, still allows them to promote SOS
mutagenesis (see below). As a consequence, it is not surprising
that by moderately overproducing the Umu proteins from low-
or medium-copy number plasmids, the equilibrium of these
protein-protein interactions can be shifted to favor one inter-
action over another. Such shifts can also be manifested in the
chromosomally expressed Umu proteins in clpX and clpP
strains so that heterodimeric UmuD+/D' formation is greatly
favored over the homodimeric complex. As demonstrated
above (Fig. 4), although this complex appears to be mutagen-
ically inactive, it is still able to interact with UmuC in such a
way as to stabilize UmuC. Such an interaction presumably
precludes the formation of an active UmuD'2C complex and
thereby renders the cell phenotypically nonmutable. Thus,
mutations that interfere with degradation of the mutagenically
active UmuD' protein result in a nonmutable phenotype.
Intriguingly, such phenotypes may be common in other organ-
isms. For example, the Saccharomyces cerevisiae RAD6 protein
is a ubiquitin-conjugating enzyme that targets proteins for
degradation (44) and mutations in RAD6 render S. cerevisiae
nonmutable (45).
SOS Mutagenesis, Despite Elaborate Mechanisms To Avoid
it! Given what now appears to be an even more elaborate
mechanism to keep the level of the E. coli UmuD'C proteins
to a minimum in wild-type cells, why is there SOS mutagenesis
after E. coli is exposed to a variety of chemical agents? One
would have to argue that only a small fraction of the total
UmuD'C proteins that are produced within the cell are
actually required for SOS mutagenesis. We have previously
estimated that there may only be 200 UmuC molecules (and
therefore UmuD'C complexes) in a fully induced cell (40).
Even if 90% of the UmuD'C complex were removed by
proteolysis, there would still be roughly stoichiometric
amounts of UmuD'C and DNA polymerase III holoenzyme
within the cell. Since the exact nature of the UmuD'2C-
polymerase III interaction that results in error-prone, trans-
lesion DNA synthesis still remains to be elucidated, it is
conceivable that the limited number of UmuD'C molecules
that escape degradation are sufficient to promote mutagenesis,
especially if they are protected from proteolysis by the forma-
tion of the "mutasome" (7, 35, 46). With the advent of a
strategy to purify a soluble UmuD'C complex (47), these
hypotheses can now be addressed biochemically.
We are extremely grateful to Susan Gottesman for bacterial strains,
stimulating discussions, and comments on the manuscript, and to
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